Antimicrobial resistance and treatment of community-acquired pneumonia

Clinics in Chest Medicine

Volumn 26, Issue 1, 2005, Pages 57-64

  Mandell, Lionel A ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFPODOXIME; CEFPROZIL; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERTAPENEM; GATIFLOXACIN; GEMIFLOXACIN; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL STRAIN; BACTERIUM ISOLATE; COMMUNITY ACQUIRED PNEUMONIA; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LOBAR PNEUMONIA; MORTALITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; UNITED STATES; WARD;

EID: 15744379053     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2004.10.005     Document Type: Review

References (21)

1. J.D. Heffelfinger, S.F. Dowell, and J.H. Jorgensen Management of community acquired pneumonia in the era of pneumococcal resistance Arch Intern Med 160 2000 1399 1408
2. K.R. Erikson Studies of induced resistance to penicillin in a pneumococcus type I Acta Pathol Microbiol Scand 22 1945 398 405
3. M.R. Jacobs, H.J. Koornhof, and H.J. Robins-Browne Emergence of multiply resistant pneumococci N Engl J Med 299 1978 735 740
4. J.H. Jorgensen, G.V. Doern, and L.A. Maher Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States Antimicrob Agents Chemother 34 1990 2075 2080
5. D. Felmingham, and R.N. Gruneberg The Alexander project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community acquired lower respiratory tract infections J Antimicrob Chemother 45 2000 191 203
6. G.V. Doern, M.A. Pfaller, and K. Kugler Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program Clin Infect Dis 27 1998 764 770
7. C.G. Whitney, M.M. Farley, and J. Hadler Increasing prevalence of multidrug resistant Streptococcus pneumoniae in the United States N Engl J Med 343 2000 1917 1924
8. S.L. Kaplan, and E.O. Mason Management of infections due to antibiotic resistant Streptococcus pneumoniae Clin Microbiol Rev 11 1998 628 644
9. J. Plouffe, R. Breiman, and R. Facklam Bacteremia with Streptococcus pneumoniae: implications for therapy and prevention JAMA 275 1996 194 198
10. T.J. Coffey, C.G. Dowson, and M. Daniels Genetics and molecular biology of beta lactam resistant pneumococci Microb Drug Resist 1 1995 29 34
11. C. Thornsberry, D.F. Sahm, and L.J. Kelly Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST surveillance program, 1999-2000 Clin Infect Dis 34 Suppl 1 2002 S4 S16
12. R. Leclercq, and P. Courvalin Resistance to macrolides and related antibiotics in Streptococcus pneumoniae Antimicrob Agents Chemother 46 2002 2727 2734
13. S.B. Levy, and M. Nelson Reversing tetracycline resistance - a renaissance for the tetracycline family of antibiotics Adv Exp Med Biol 456 1998 17 25
14. D. Chen, A. McGeer, and J.C. de Azavedo The Canadian Bacterial Surveillance Network: decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada N Engl J Med 341 1999 233 239
15. J.A. Karlowsky, C. Thornsberry, and M.E. Jones Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998-2002) Clin Infect Dis 36 2003 963 970
16. Centers for Disease Control and Prevention Resistance of Streptococcus pneumoniae to fluoroquinolones - United States, 1995-1999 MMWR Morb Mortal Wkly Rep 50 2001 800 804
17. D. Feikin, A. Schuchat, and M. Kolczak Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance Am J Public Health 90 2000 223 229
18. J.R. Lonks, J. Garau, and L. Gomez Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae Clin Infect Dis 1 2002 556 564
19. R. Davidson, R. Cavalcanti, and J.L. Brunton Resistance to levofloxacin ad failure of treatment of pneumococcal pneumonia N Engl J Med 346 2002 747 750
20. L.A. Mandell, J.G. Bartlett, and S.F. Dowell Update of practice guidelines for the management of community acquired pneumonia in immunocompetent adults Clin Infect Dis 37 2003 1405 1433
21. M. Lujan, M. Gallego, and D. Fontanals Prospective observational study of bacteremic pneumococcal pneumonia: effect of discordant therapy on mortality Crit Care Med 32 3 2004 625 631